What Researchers Did
Researchers investigated nitric oxide levels in wound fluid and plasma of 6 chronic wound patients undergoing hyperbaric oxygen therapy (HBOT).
What They Found
Wound fluid nitric oxide (NOx) levels tended to increase during hyperbaric oxygen therapy (HBOT) and were significantly elevated at 1 and 4 weeks post-treatment. These elevated levels correlated with reductions in wound area, while plasma L-arginine and asymmetric dimethylarginine remained unchanged.
What This Means for Canadian Patients
For Canadian patients with chronic wounds, hyperbaric oxygen therapy (HBOT) may promote healing by increasing local nitric oxide levels in the wound. This could lead to better wound closure and improved outcomes for those undergoing this treatment.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian participants.
Study Limitations
This was a preliminary study with a very small sample size of only 6 patients, limiting the generalizability of the findings.